Ponatinib and platelets a conflict in CML

Abstract

In this issue of Blood, Lafiti et al address the critical question of vascular and cardiac toxicity of ponatinib, using a mouse model.1 They elegantly show that ponatinib vascular toxicity is due to von Willebrand factor (VWF)-mediated platelet adhesion.